Catalyst Wire Dossier Catalyst Wire Dossier

GRC 17536

GRC-17536 · Glenmark Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GRC 17536, covering 2012-11-12 to 2014-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). [Phase 2]

See pricing